Today is a milestone in the world of biosimilars, as the first Humira® biosimilar Amjevita™ (adalimumab-atto), manufactured by Amgen, has launched in the U.S. Will it…
Revolutionary Drug Management Reporting Tool Offers Powerful User Insights Dallas, TX (January 23, 2023) – Artemetrx®, the industry’s most preeminent platform for integrated drug cost…
Republished with Permission from AIS Health The FDA recently approved the first novel long-acting granulocyte colony-stimulating factor (G-CSF) in more…
Choosing, negotiating a contract, and navigating a relationship with a pharmacy benefit manager (PBM) isn’t one size fits all. No single PBM is “best”…
Customer Satisfaction Report Dives into Current PBM Sentiment by Plan Sponsors DALLAS, TX – Pharmaceutical Strategies Group (PSG), an EPIC company, has released its…
Much has been written about the sweeping changes contained in the Inflation Reduction Act of 2022 (IRA), including provisions that affect drug pricing. I’ve…
Get the Full Analysis of the Big 3 Formulary Changes: 2023 Formulary Changes: CVS Health 2023 Formulary Changes: Express Scripts 2023 Formulary Changes: OptumRx…